Pharmed Limited, headquartered in India’s Silicon Valley, Bangalore, is now one of the fastest-growing pharmaceutical companies in the country. For over seven decades, since 1946, Pharmed has been consistently carrying on its legacy of ‘Caring for India’ and helping millions of users improve quality of life. In a journey that started over 70 years ago, Pharmed has become a name to be reckoned with among the Indian medical fraternity, with its innovative range of products that have changed disease management by enhancing lifestyle. Evidence-based pharmaceutical and nutraceutical products are at the heart of Pharmed, and are regularly promoted among Gynaecologists, Orthopaedic Surgeons, Physicians, Dermatologists and Otolaryngologists, for our prescription driven Business.
Our quest to cater unmet needs across specialized therapy areas and our fervent belief in quality and innovative formulations have created opportunities for Pharmed to produce several ‘First time in India’ brands based on strong evidence. Our nationwide sales and marketing force, supported by an efficient distribution network and well-structured support departments stationed at our state-of-the-art Corporate office has made Pharmed an eminent name in the Indian Pharmaceutical Market.
| Pharmed Limited Outstanding Shares: | 4306200 |
| Face Value of Pharmed Limited Delisted Share: | Rs.2 Per Equity Share |
| ISIN of Pharmed Limited Delisted Share: | INE0EEI01017 |
| Lot Size of Pharmed Limited Share: | 1000 |
| Pharmed Limited Share Price: | Best In Industry |
| PAN Number of Pharmed Limited : | AAACP2191A |
| GST Number of Pharmed Limited : | 27AAACP2191A1ZV |
Pharmed Limited CIN Number |
U24230MH1946PLC005121 |
Pharmed Limited Registration Date |
10-08-1946 |
| Category / Sub-Category of PHARMED Company Limited | Company Limited by Shares / Indian Non Government Company |
Pharmed Limited Registered Office Address |
"Pharmed House" ,141, walchand hirachand marg, Bombay - 400001 |
|
Board of Directors Constituents |
Post |
|
Mr. S.N. Agarwal |
Independent Director |
|
Dr. Jagdish Chinnappa |
Independent Director |
|
Mr. K.K. Aurora |
Chairman Emeritus , Non Executive Director |
|
Mr. Suneet Aurora |
Chairman & Managing Director |
|
Mr. K.L. Kapoor |
Whole Time Director |
|
Mr. V. Krishnamurthy |
Whole Time Director |
|
Mr. N.B. Shroff |
Whole Time Director |
|
Mrs. Yogesh Saran Aurora |
Whole Time Director |
|
Name and Description of main products/services |
% to the total turnover of the Company |
|
Pharmaceutical and Nutraceutical products |
100.00% |
|
Name of the Company |
Subsidiary / Associate |
% of shares held |
|
Sunora Investments Private Limited |
Subsidiary |
100.00% |
|
Particulars |
No. of Shares |
% of Shareholding |
|
Promoters |
39,51,783 |
91.77% |
|
Others |
3,54,417 |
8.23% |
|
Total |
43,06,200 |
100.00% |
FAQ's on Pharmed
Q: What
is the face value of Pharmed Ltd shares?
Answer: The face value of Pharmed Ltd is ₹2 per equity share.
Q: What
is the minimum lot size for buying Pharmed Ltd shares through WWIPL?
Answer: The minimum lot size for Pharmed Ltd shares is 1000 equity
shares.
Q: How
can I buy Pharmed Ltd unlisted shares through WWIPL?
Answer: Investors can complete KYC, confirm the transaction via WWIPL,
transfer funds, and receive shares directly in their Demat account.
Q: Why
should I buy Pharmed Ltd shares through WWIPL?
Answer: WWIPL provides transparent pricing, secure execution, seamless
Demat transfer, and support for unlisted share transactions.
Q: Is
investing in Pharmed Ltd a good idea?
Answer: Investors typically evaluate Pharmed Ltd based on its
pharmaceutical product portfolio, manufacturing capabilities, regulatory
compliance, financial performance, and long-term healthcare demand.
Q: Why do
investors buy Pharmed Ltd shares before a potential IPO?
Answer: Investors seek early exposure to a pharma company before
listing, aiming to participate in future value creation and liquidity
opportunities.
Q: What
business does Pharmed Ltd operate in?
Answer: Pharmed Ltd is engaged in the pharmaceutical sector, focused on
manufacturing and distribution of formulations and healthcare products.
Q: What
makes Pharmed Ltd different from other unlisted pharma companies?
Answer: The company operates in pharmaceutical formulations with focus
on healthcare products, quality manufacturing, and distribution across domestic
and institutional markets.
Q: What
are the key growth drivers for Pharmed Ltd?
Answer: Rising healthcare demand, expansion of pharmaceutical distribution,
product diversification, regulatory approvals, and growth in domestic and
export pharma markets are key growth drivers.
Q: What
factors affect the valuation of Pharmed Ltd shares?
Answer: Revenue growth, product pipeline, margins, regulatory compliance,
manufacturing capacity, profitability, and demand for pharmaceutical products
influence valuation.
Q: Are
Pharmed Ltd shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to
the investor’s Demat account.
Q: Can I
sell my Pharmed Ltd shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted
shares, subject to market demand and availability.
Q: What
documents are required to buy Pharmed Ltd shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report
(CMR), and bank account details to complete the transaction.
Q: What
are the risks of investing in Pharmed Ltd shares?
Answer: Risks include regulatory changes, product approval delays,
competition in pharma markets, pricing pressure, and liquidity constraints in
unlisted shares.
Q: How
does WWIPL help investors track Pharmed Ltd investments?
Answer: WWIPL provides company updates, transaction assistance, market
insights, and investment support to help investors stay informed.
Q: How
long does it take for Pharmed Ltd shares purchased through WWIPL to be credited
to a Demat account?
Answer: Shares are generally transferred after successful transaction
verification and credited within standard settlement timelines.
Q: What
should investors evaluate before investing in Pharmed Ltd?
Answer: Investors should assess product pipeline, manufacturing
strength, financial performance, profitability, valuation, and long-term
healthcare demand outlook.
Q: Can
Pharmed Ltd benefit from India’s growing pharmaceutical sector?
Answer: Yes. Rising healthcare demand, increasing domestic consumption,
and export opportunities may support long-term growth potential for the
company.